Processing of the samples in molecular diagnostics is complex and labor-intensive. Here, the authors present a prototype of a versatile and integrated platform for the detection of pathogens in various liquid media.
This study delves aims to evaluate the efficacy of durancin 61A as an inhibitor of resistant clinical pathogens and to shed light on its mode of action.
Although understanding of Ebola virus pathogenesis has rapidly increased recently, many questions relating to the role of the vascular system remain unanswered. The authors here discuss how Ebola virus infection can cause endothelial dysfunction and coagulopathy.
This editorial presents some of the latest evidence to support the antivirulence approach, highlighting at the same time some of the issues that need to be considered when evaluating antivirulence drugs.
How can we ensure products remain pathogen free? In this editorial, the authors discuss the most common causes of food-borne illnesses, methods by which contamination is traditionally detected and what current research has to offer, specifically in the field of nanoscience.
In this original research article, the authors determine the structural contributions of a compound set containing inhibitors of bacterial enzyme FabI.
Despite an urgent need for a universal flu vaccine there is no such vaccine in the market and no regulatory guideline for its approval. This special report from Future Virology proposes a stepwise process for regulatory and marketing approval for such a vaccine and discusses the epitope-based vaccine candidate Multimeric-001 (M-001).
In this editorial the author examines the initiatives taken by Drugs for Neglected Diseases (DNDi) and Medicines Patent Pool (MPP) organizations to improve access to pan-genotypic hepatitis C treatment.
In this editorial the authors discuss conventional diagnostic approaches and alternative diagnostic tests, which could be used in the future.